REVIEW
Published on 29 Jan 2026
Spatial profiling of the metabolism-immune axis in ovarian cancer
doi 10.3389/fphar.2025.1672020
- 519 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Advances in Ovarian Cancer Therapeutics
Advances in Ovarian Cancer Therapeutics
3,817
Total downloads
28k
Total views and downloads
Articles
REVIEW
Published on 22 Jan 2026
Natural compounds in ovarian cancer: mechanistic insights and therapeutic potential
doi 10.3389/fphar.2025.1687805
- 411 views
ORIGINAL RESEARCH
Published on 08 Jan 2026
Signals of interstitial lung disease with novel antineoplastic agents in ovarian cancer: a three-database disproportionality study
doi 10.3389/fphar.2025.1682276
- 691 views
REVIEW
Published on 12 Dec 2025
Clinical relevance of PLK1 in epithelial ovarian cancer
doi 10.3389/fphar.2025.1702273
- 986 views
REVIEW
Published on 26 Nov 2025
The immunotherapy era in ovarian clear cell carcinoma: current evidence and future perspective
doi 10.3389/fimmu.2025.1661048
- 2,978 views
SYSTEMATIC REVIEW
Published on 10 Nov 2025
Comparative effectiveness and safety of immunotherapeutic strategies in ovarian cancer: a systematic review and network meta-analysis
doi 10.3389/fonc.2025.1659897
- 1,640 views
SYSTEMATIC REVIEW
Published on 27 Oct 2025
Stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (OMOC): a systematic review and meta-analysis of clinical outcomes and toxicity profiles
doi 10.3389/fphar.2025.1620922
- 1,268 views
REVIEW
Published on 17 Jul 2025
Progress of targeted FOX family therapy in ovarian cancer
doi 10.3389/fphar.2025.1604998
- 1,493 views
ORIGINAL RESEARCH
Published on 05 Jun 2025
A novel mitochondrial autophagy and aging-related gene signature for predicting ovarian cancer
doi 10.3389/fimmu.2025.1594021
- 3,663 views
ORIGINAL RESEARCH
Published on 04 Jun 2025
Integrated machine learning and single-cell analysis reveal the prognostic and therapeutic potential of SUMOylation-related genes in ovarian cancer
doi 10.3389/fimmu.2025.1577781
- 3,854 views
- 1 citation
ORIGINAL RESEARCH
Published on 29 May 2025
The potential of ME1 in guiding immunotherapeutic strategies for ovarian cancer: insights from pan-cancer research
doi 10.3389/fimmu.2025.1571842
- 2,485 views
MINI REVIEW
Published on 24 Apr 2025
Research progress on ferroptosis and PARP inhibitors in ovarian cancer: action mechanisms and resistance mechanisms
doi 10.3389/fphar.2025.1598279
- 3,731 views
- 3 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore